Aravind Palraj / X
Jul 22, 2025, 09:17
Decoding Antiphospholipid Syndrome: Why Triple Positivity Is a Red Flag for Thrombosis
Aravind Palraj, MD highlights a crucial message on his X page:
”Antiphospholipid antibodies (aPL) are key to diagnosing APS—but timing, type, and persistence matter.
Triple positive? Highest thrombosis risk.
Test smart. Interpret wisely.”
Want to dive deeper into Antiphospholipid Syndrome?
On Hemostasis Today, you can explore in-depth, clinically relevant, and first-hand academic knowledge on:
- Diagnostic strategies for APS
- Role of Lupus Anticoagulant, anticardiolipin, and β2-GPI antibodies
- Risk stratification and management approaches in triple-positive patients
- Anticoagulation dilemmas in APS
-
Dec 11, 2025, 12:30A Neutrophil-Mesangial Cell Axis Promotes Glomerular Injury in Lupus Nephritis
-
Dec 11, 2025, 12:27Roula Farah: Discussing Rare Bleeding Disorders in Abu Dhabi
-
Dec 11, 2025, 12:21Amirali Ebrahimpour: Escherichia coli–Related DIC Case Report
-
Dec 11, 2025, 12:08Laura Girardi Compares US, CT and MRI in Portal Vein Thrombosis
-
Dec 11, 2025, 11:55Dino Mehic on BDUC: What Do We Know?
-
Dec 11, 2025, 11:39Post‑ASH25 Reflection from Hollie Knight: The Magic Isn’t Just in the Data, It’s in How We Move It
-
Dec 11, 2025, 06:23Robert Negrin is the President of ASH for 2026
-
Dec 10, 2025, 23:50Abdul Mannan: Two Battles, One Patient – Why Women on Anticoagulants Need Better Coordinated Care
-
Dec 10, 2025, 22:36Susan Galbraith on AstraZeneca’s Grand Presence at ASH25